• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Company Analysis - Biocon Limited Product Image

Company Analysis - Biocon Limited

  • Published: April 2011
  • Region: Global
  • 30 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Novartis AG
  • Wockhardt Limited
  • MORE

Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.

The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.

The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.

Report Highlights

- Provides a comprehensive version of the company's performance

- Offers key financial data, ratio and SWOT analysis

- Tracks major M&A trends and developments

- Business Profile, SWOT analysis and financial information on top competitors

- View on the company by our analysts

- Supplemented with graphs and tabular information wherever necessary

1. Company Overview
1.1 History
1.2 Business Overview
1.3 Organizational Structure
1.4 Ticker Codes at various Stock Exchange Listings
1.5 Major Mergers & Acquisitions
1.6 Management Profile

2. Product & Services
2.1 Product & Services - An Overview
2.2 Revenue & Income Summary by Business Segment
2.3 Revenue & Income Summary by Geographical Distribution

3. Financial Information for the Fiscal Year
3.1 Financial Summary for the Fiscal Year
3.2 Breakup of Revenue & Sales Trends
3.3 Ratio & Market Indicators
3.4 Earning & Income Estimates
3.5 Stock Analysis

4. SWOT Analysis
4.1 Strength
4.2 Weaknesses
4.3 Opportunity
4.4 Threats

5. Top Competitors (Key Financials & SWOT Analysis)
5.1 Wockhardt Limited
5.2 Dr. Reddy's Laboratories Limited
5.3 Sun Pharmaceuticals Industries Ltd.
5.4 Ranbaxy Laboratories Limited
5.5 Novartis AG

6. Analyst View

List of Tables

Table 1-1: Biocon Limited - Ticker Codes at various Stock Exchanges
Table 1-2: Biocon Limited - Major Mergers & Acquisitions (2005 to 2010)
Table 1-3: Biocon Limited - Key Management People
Table 3-1: Biocon Limited - Financial Overview (Million US$), FY 2010
Table 3-2: Biocon Limited - Breakup of Revenue & Sales (Million US$), FY 2008 to FY 2010
Table 3-3: Biocon Limited - Key Financial Ratios (FY 2008 to FY 2010)
Table 3-4: Biocon Limited - Earning & Income Estimates (Million US$), FY 2008 to FY 2010
Table 5-1: Wockhardt Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-2: Wockhardt Limited - SWOT Analysis
Table 5-3: Dr. Reddy's Laboratories Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-4: Dr. Reddy's Laboratories Limited - SWOT Analysis
Table 5-5: Sun Pharmaceuticals Industries Ltd. - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-6: Sun Pharmaceuticals Industries Ltd. - SWOT Analysis
Table 5-7: Ranbaxy Laboratories Limited - Key Financials (Million US$), 2007-2009
Table 5-8: Ranbaxy Laboratories Limited - SWOT Analysis
Table 5-9: Novartis AG - Key Financials (Million US$), 2007-2009
Table 5-10: Novartis AG - SWOT Analysis

List of Charts

Figure 2-1: Biocon Limited – Total Revenue by Business Segment (Million US$), FY 2009 & FY 2010
Figure 2-2: Biocon Limited - Revenue by Geographical Distribution (Million US$) FY 2009 & FY 2010
Figure 3-1: Biocon Limited - Stock Chart

- Wockhardt Limited
- Dr. Reddy's Laboratories Limited
- Sun Pharmaceuticals Industries Ltd.
- Ranbaxy Laboratories Limited
- Novartis AG

Note: Product cover images may vary from those shown

RELATED PRODUCTS